Pulmonary valve stenosis in a recipient twin in twin-to-twin transfusion syndrome with successful balloon valvuloplasty after birth: a case report

Twin-to-twin transfusion syndrome (TTTS) is a severe complication in monochorionic (MC) twin pregnancies. It is associated with fetal and neonatal cardiac dysfunction, especially in recipient twin. Acquired heart dysfunction is seen in recipient twins who complicated with ventricular hypertrophy, cardiomegaly and atrio-ventricular valves regurgitation [1]. In MC pregnancies with TTTS, the risk of at least one of the infants with CHD is threefold, as compared with uncomplicated MC twin pregnancies [2]. The development of acquired CHDs in MC twins is associated with TTTS, indicating an influence of hemodynamic alterations on cardiac development. MC twins with TTTS are associated with increased risk of ventricular septal defect (VSD), right ventricular outflow tract obstruction (RVOTO), atrial septal defect (ASD), coarctation of aorta (CoA), and aortic stenosis (AS) [3]. RVOTO may occur in the recipient twin of at least 9% of MC twin pregnancies that complicated with TTTS [4]. The likely etiology of RVOTO in recipient twins in TTTS is altered fetal circulation and right ventricular hypertrophy [5, 6]. Fetoscopic laser therapy has significant effect on heart function of donor and recipient twins of TTTS. Some of these cardiac disorders that are due to hemodynamic changes in TTTS improve after laser treatment, but some remain. Therefore, The diagnosis and follow up of PS/PA after laser treatment of TTTS is important because despite intervention, 35/7% of recipient twins die, 32.1% shows in utero regression and 32.1% has persistence of PS/PA [7]. Infundibular pulmonary stenosis (IPS) is a pathologic feature of the right tract from the right ventricular outflow tract to the peripheral pulmonary arteries at the infundibular level [8]. It can cause right ventricular hypertrophy and early treatment can lead to reduction of right ventricular pressure. Propranolol reduces the infundibular obstruction, but some cases need surgery [9].

A 27-year-old pregnant woman, primigravida, MC twin pregnancy, with a gestational age of 21 weeks was referred to our center due to TTTS stage 3. Her pregnancy was a product of in vitro fertilization (IVF). She had no history of medical disease or drug usage. Fetal echocardiography showed biventricular hypertrophy, cardiomegaly (Fig. 1) and severe pulmonary valve stenosis (PS) (Figs. 2 and 3) in recipient twin. No other major anomalies were detected in the both fetuses. Fetoscopic laser photocoagulation (FLP) was done at our center due to TTTS stage 3. After that, the course of the TTTS stopped, but PS persisted (Fig. 4) with presence of severe tricuspid valve regurgitation (Fig. 5) and at 32 weeks of gestation, the pregnancy was terminated by cesarean section due to fetal growth restriction (FGR) and absent Doppler wave in umbilical artery of recipient twin. Both babies were born with good APGAR score. After birth, in transthoracic echocardiography of recipient twin, Doppler spectral showed severe PS with peak pressure gradient more than 100 mmHg (Fig. 6). Contrast injection in lateral view of angiocardiography detected severe valvular and sub valvular pulmonary stenosis (Fig. 7). After birth, due to the persistence of stenosis, After initiation of prostaglandin infusion, the recipient twin underwent balloon pulmonary valvuloplasty at the age of one month, when the weight of baby was 1300 g with heart rate:155–160/min, respiratory rate:70/min, O₂ saturation > 75–80, lactic acid(in ABG):12. The baby was under mechanical ventilation with SIMV PC mode and the preoperative trans thoracic echocardiography showed right ventricular hypertrophy (decreased end diastolic diameter), significant TR, small pulmonary annulus, small PDA (diameter = 2 mm with left to right shunt) and PFO with dominant right to left shunt. Balloon inflation of stenotic pulmonary valve in stenotic location showed a full dilation of stenosis (Fig. 8). Post procedure transthoracic echocardiography showed significant reduction in transpulmonary valve gradient (Fig. 9). Due to dynamic infundibular (subvalvular) stenosis and persistence of high transpulmonary valve gradient (about 100 mmHg), propranolol with maximum dose of 2 mg/kg was started and after 4 weeks, the gradient reduced from 100 to 30 mmHg. The baby had a good growth after treatment, with 3700 g weigh after three months.

PS/pulmonary atresia (PA) is a serious complications of MC twin pregnancies with TTTS, in recipient twin. The common abnormal cardiac presentation in recipient twins are ventricular hypertrophy and cardiomegaly, but PS/PA is rare. Recipient twins can develop progressive ventricular hypertrophy, diastolic dysfunction, and finally RVOTO and PS/PA [10, 11]. Postnatally, some need percutaneous balloon pulmonary valvuloplasty or surgical valvotomy. Critical PS causes cyanosis and can be lethal in infants. After initiation of prostaglandin infusion, percutaneous balloon valvuloplasty is the treatment of choice [12]. This procedure was done in our case successfully and IPS had a good response to propranolol. Murakoshi T. [13] reported 3 cases of pulmonary stenosis in the recipient twin in twin-twin transfusion syndrome. Two cases underwent postnatal balloon valvuloplasty to release the pulmonary valvular stenosis in neonatal period. The third one died soon after delivery and autopsy showed a slightly thickened pulmonary valve. Ortiz JU. [7] carried out a prospective study including 260 cases of TTTS, in which PS was observed in 16 out of 260 of recipient twins (6.2%). In above-mentioned study, Postnatally, seven recipients underwent percutaneous balloon pulmonary valvuloplasty just like the case we presented and one required surgical valvotomy.

It is important to detect acquired cardiac abnormalities in MC twins with TTTS, and follow up even if they are treated with fetoscopic laser photocoagulation during pregnancy and after birth to determine the need of intervention in neonatal period.